Reset filters
  • 9 May 2013

Movement for global access to hepatitis C treatment building momentum

Read the article
  • 7 May 2013

Report highlights major failings in UK response to hepatitis C

Read the article
  • 2 May 2013

Daclatasvir + asunaprevir + BMS-791352 looks promising as interferon-free combination

Read the article
  • 30 April 2013

Compassionate access to new hepatitis C drugs an "emergency" for European patients

Read the article
  • 30 April 2013

Second-generation HCV protease inhibitor simeprevir pushes triple therapy cure rate up to 80%

Read the article
  • 30 April 2013

Second-generation protease inhibitor faldaprevir cures up to 80% of hepatitis C

Read the article
  • 30 April 2013

Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis

Read the article
  • 29 April 2013

Hep C quad regimens quashed, but some components go forward

Read the article
  • 29 April 2013

Daclatasvir + sofosbuvir offers hepatitis C rescue therapy after current standard of care

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.